These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6411312)

  • 1. [Inhibition of the growth of bacterial populations by suspensions obtained from Pseudomonas aeruginosa pyocinogenic strains].
    García-Quintana HG; Flores ME
    Can J Microbiol; 1983 May; 29(5):471-5. PubMed ID: 6411312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bactericidal spectrum of pyocins on strains collected at Region IX and X hospitals in Chile].
    García-Quintana HG; Polette M; Ríos J
    Rev Med Chil; 1989 Jun; 116(6):543-8. PubMed ID: 2501848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pyocin types and proteolytic properties of Pseudomonas pyocyanea organisms in burned patients and in the milieu of the Division of Burns, Institute of Hematology in Warsaw].
    Bukowska D; Serafińska D; Nasilowski W; Zietkiewicz W
    Pol Tyg Lek; 1976 Jun; 31(26):1107-10. PubMed ID: 821048
    [No Abstract]   [Full Text] [Related]  

  • 4. Purification and characterization of pyocins R from Pseudomonas aeruginosa.
    al-Rubiee R; al-Mudaffar S; Hassan F; al-Ani F
    Folia Microbiol (Praha); 1988; 33(6):520-4. PubMed ID: 3149253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro inhibition of the growth of Gardnerella vaginalis by bacteriocins produced by strains of Pseudomonas aeruginosa].
    Barberis IL; Pájaro MC; Godino SD; Aichino C
    Enferm Infecc Microbiol Clin; 1997 Nov; 15(9):473-6. PubMed ID: 9527372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possibility of using purified pyocins for typing Pseudomonas aeruginosa: purification of pyocins and sensitivity of P. aeruginosa in different tests.
    Jurado Chacon D; Chueca Sancho A; Guillen Solvas JF; Garcia-Villanova Ruiz B; Galvez Vargas R
    Ann Inst Pasteur Microbiol (1985); 1986; 137A(3):253-66. PubMed ID: 3122639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation, purification and characterization of a pyocin.
    Faydi YR; Nabbut NH
    Ann Microbiol (Paris); 1978 Apr; 129(3):313-22. PubMed ID: 96719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pseudomonas aeruginosa strains: synergism and pyocinogenia induction].
    García-Quintana HG; Martińez MA
    Rev Med Chil; 1988 Nov; 116(11):1167-71. PubMed ID: 3151707
    [No Abstract]   [Full Text] [Related]  

  • 9. R-type pyocin is required for competitive growth advantage between Pseudomonas aeruginosa strains.
    Heo YJ; Chung IY; Choi KB; Cho YH
    J Microbiol Biotechnol; 2007 Jan; 17(1):180-5. PubMed ID: 18051371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of pyocins from Pseudomonas aeruginosa.
    Al-Shibib A; Al-Mudhaffar S; Al-Ani F; Hassan F
    Folia Microbiol (Praha); 1985; 30(1):25-9. PubMed ID: 3920127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the biosynthesis and morphogenesis of R-type pyocins of Pseudomonas aeruginosa. IV. Quantitative estimation of the rates of synthesis of pyocin R subunit proteins.
    Shinomiya T
    J Biochem; 1974 Nov; 76(5):1083-94. PubMed ID: 4217793
    [No Abstract]   [Full Text] [Related]  

  • 12. Level of resistance of clinical isolates of Pseudomonas aeruginosa as related to their susceptibility to phages and R-pyocins.
    Legakis N; Koukoubanis N; Malliara K; Tumah H
    Chemioterapia; 1987 Jun; 6(2 Suppl):200-1. PubMed ID: 3151342
    [No Abstract]   [Full Text] [Related]  

  • 13. [Quantitative and qualitative measurement of the activity of pyocins of Ps. aeruginosa (author's transl)].
    García Quintana H; Asenjo S; Hernández A; Polette M
    Rev Med Chil; 1979 Jun; 107(6):471-8. PubMed ID: 120964
    [No Abstract]   [Full Text] [Related]  

  • 14. [Bacteriocinogeny in Pseudomonas aeruginosa].
    Maresz-Babczyszyn J; Sokalska M
    Med Dosw Mikrobiol; 1977; 29(3):179-89. PubMed ID: 412020
    [No Abstract]   [Full Text] [Related]  

  • 15. [Second possibility of employing typization of Pseudomonas aeruginosa by means of pyocins (pyocinotypia) (author's transl)].
    Zahradnický J
    Cesk Epidemiol Mikrobiol Imunol; 1979 Nov; 28(6):321-5. PubMed ID: 161865
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo significance of bacteriocins and bacteriocin receptors.
    Govan JR
    Scand J Infect Dis Suppl; 1986; 49():31-7. PubMed ID: 3103211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the host range specificity of pyocin P1.
    Brandis H; Krämer J; Israil A
    Arch Roum Pathol Exp Microbiol; 1975; 34(1-2):13-20. PubMed ID: 813612
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of Neisseria gonorrhoeae by a bacteriocin from Pseudomonas aeruginosa.
    Morse SA; Vaughan P; Johnson D; Iglewski BH
    Antimicrob Agents Chemother; 1976 Aug; 10(2):354-62. PubMed ID: 825024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa Soluble Pyocins as Antibacterial Weapons.
    Cornelis P; Dingemans J; Baysse C
    Methods Mol Biol; 2024; 2721():125-136. PubMed ID: 37819519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial proteinaceous products (bacteriocins) as cytotoxic agents of neoplasia.
    Farkas-Himsley H; Cheung R
    Cancer Res; 1976 Oct; 36(10):3561-7. PubMed ID: 953984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.